Document is current
Any future updates will be listed below
-
Authors
Inojosa, Hernan
Schriefer, Dirk
Ness, Nils-Henning
Dillenseger, Anja
Akgün, Katja
Ziemssen, Tjalf https://orcid.org/0000-0001-8799-8202
-
Funding
Funding for this research was provided by:
Technische Universität Dresden
- License Information
-
More Information
Article History
Received: 11 October 2024
Revised: 16 November 2024
Accepted: 19 November 2024
First Online: 17 January 2025
Declarations
:
: HI received speaker honoraria from Roche and financial support for research activities from Teva, Biogen, and Alexion. N-HN is an employee of Hexal AG. K.A. received personal compensation from Novartis, Biogen Idec, Teva, Sanofi, and Roche for consulting services. TZ reports scientific advisory board and/or consulting for Biogen, Roche, Novartis, Celgene, and Merck; compensation for serving on speakers bureaus for Roche, Novartis, Merck, Sanofi, Celgene, and Biogen; and research support from Biogen, Novartis, Merck, and Sanofi. DS and AD have nothing to declare.
: This article does not contain any studies with human participants or animals performed by any of the authors.
